Literature DB >> 9108983

Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems.

D Verotta1.   

Abstract

The response at time t (R(t)) of a (causal linear time invariant) system to an input A(t) is represented by: [equation: see text] where K(t) is called the unit impulse response function of the system, and the integration on the right side of the equation (above) is called the convolution (from the latin cum volvere: to interwine) of A(t) and K(t). The system described by this equation is at zero (initial conditions) when t = 0. Although it does not even begin to describe the incredible variety of possible responses of biological systems to inputs, this representation has large applicability in biology. One of the most frequently used applications is known as deconvolution: to deinterwine R(t) given a known K(t) (or A(t)) and observations of R(t), to obtain A(t) (or K(t)). In this paper attention is focused on a greater variety of aspects associated with the use of linear systems to describe biological systems. In particular I define causal linear time-invariant systems and their properties and review the most important classes of methods to solve the deconvolution problem, address. The problem of model selection, the problem of obtaining statistics and in particular confidence bands for the estimated A(t) (and K(t)), and the problem of deconvolution in a population context is also addressed, and so is the application of linear system analysis to determine fraction of input absorbed (bioavailability). A general model to do so in a multiinput-site linear system is presented. Finally the application of linear system analysis to control a biological system, and in particular to target a desired response level, is described, and a general method to do so is presented. Applications to simulated, endocrinology, and pharmacokinetics data are reported.

Mesh:

Substances:

Year:  1996        PMID: 9108983     DOI: 10.1615/critrevbiomedeng.v24.i2-3.10

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  19 in total

1.  Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.

Authors:  Franziska Schaedeli; Maria Pitsiu; Neal L Benowitz; Steven G Gourlay; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

3.  Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum.

Authors:  Maria Pitsiu; Jean-Michel Gries; Neal Benowitz; Steven G Gourlay; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

4.  Volterra series in pharmacokinetics and pharmacodynamics.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-10       Impact factor: 2.745

5.  Sample size computations for PK/PD population models.

Authors:  Dongwoo Kang; Janice B Schwartz; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

6.  The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Authors:  Chantal Csajka; David Drover; Davide Verotta
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

Review 7.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

8.  An efficient deconvolution algorithm for estimating oxygen consumption during muscle activities.

Authors:  Ranjan K Dash; Erkki Somersalo; Marco E Cabrera; Daniela Calvetti
Journal:  Comput Methods Programs Biomed       Date:  2007-01-31       Impact factor: 5.428

9.  A note on population analysis of dissolution-absorption models using the inverse Gaussian function.

Authors:  Jian Wang; Michael Weiss; David Z D'Argenio
Journal:  J Clin Pharmacol       Date:  2008-03-21       Impact factor: 3.126

10.  A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies.

Authors:  Shuhua Hu; Michael Dunlavey; Serge Guzy; Nathan Teuscher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-01-24       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.